SEGMENTED INFORMATION (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
REVENUE	$ 2,566,848		$ 2,485,101		$ 4,944,053	$ 5,514,046
COST OF REVENUE	(2,227,134)		(2,221,130)		(4,235,442)	(4,893,742)
GROSS PROFIT	339,714		263,971		708,611	620,304
OTHER INCOME	195,164		52,848		312,508	99,230
General and administrative					(1,343,949)	(822,807)
(LOSS)/PROFIT FROM OPERATIONS	(272,199)		(137,964)		(322,830)	(103,273)
FINANCE COSTS					(5,487)	(5,645)
(LOSS)/PROFIT BEFORE TAX	(275,241)		(140,283)		(328,317)	(108,918)
Tax expense					0	(12,678)
Net loss	$ (259,251)	$ (69,066)	$ (138,662)	$ 17,066	(328,317)	(121,596)
BioNexus Malaysia [Member]
REVENUE					11,932	33,467
COST OF REVENUE					(7,548)	(14,929)
GROSS PROFIT					4,384	18,538
OTHER INCOME					2,165	4,285
General and administrative					(98,720)	(94,681)
(LOSS)/PROFIT FROM OPERATIONS					(92,171)	(71,858)
FINANCE COSTS					(1,275)	(1,860)
(LOSS)/PROFIT BEFORE TAX					(93,446)	(73,718)
Tax expense					0	0
Net loss					(93,446)	(73,718)
Chemrex [Member]
REVENUE					4,932,121	5,480,579
COST OF REVENUE					(4,227,894)	(4,878,813)
GROSS PROFIT					704,227	601,766
OTHER INCOME					310,343	94,945
General and administrative					(1,025,896)	(618,348)
(LOSS)/PROFIT FROM OPERATIONS					(11,326)	78,363
FINANCE COSTS					(4,212)	(3,785)
(LOSS)/PROFIT BEFORE TAX					(15,538)	74,578
Tax expense					0	(12,678)
Net loss					(15,538)	61,900
BGLC [Member]
REVENUE					0	0
COST OF REVENUE					0	0
GROSS PROFIT					0	0
OTHER INCOME					0	0
General and administrative					(219,333)	(109,778)
(LOSS)/PROFIT FROM OPERATIONS					(219,333)	(109,778)
FINANCE COSTS					0	0
(LOSS)/PROFIT BEFORE TAX					(219,333)	(109,778)
Tax expense					0	0
Net loss					$ (219,333)	$ (109,778)